ASTRAZENECA PHARMACEUTICALS LP
ASTRAZENECA PHARMACEUTICALS LP is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| ASTRAZENECA PHARMACEUTICALS LPThe registrant lobbying for itself | 2026-Q2: $1,680,000 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- BAILEY LAUREN MCCUE · 1 report · earlier government job reported
- CAROLINE QUAT · 1 report
- KATIE JONES · 1 report
- LISA LANGENDERFER · 1 report
- SARAH CUDWORTH ARBES · 1 report
- TALEEN MEKHDJAVAKIAN · 1 report · earlier government job reported
Bills named, and how the House and the Senate voted
16 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 591Defending American Jobs and Investment Act | Introduced | No recorded vote in our record |
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1414Cameron’s Law | Introduced | No recorded vote in our record |
| H.R. 1911To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subject to sufficient foreign tax are not treated as base erosion payments. | Introduced | No recorded vote in our record |
| H.R. 1990American Innovation and R&D Competitiveness Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 3521Clinical Trial Modernization Act | Introduced | No recorded vote in our record |
| H.R. 5509Safe Step Act | Introduced | No recorded vote in our record |
| H.R. 7118Genomic Answers for Children’s Health Act of 2026 | Introduced | No recorded vote in our record |
| H.R. 9599SECURE 340B Act | Introduced | No recorded vote in our record |
| S. 1605International Competition for American Jobs Act | Introduced | No recorded vote in our record |
| S. 1637MVP Act | Introduced | No recorded vote in our record |
| S. 1639American Innovation and Jobs Act | Introduced | No recorded vote in our record |
| S. 1862ORPHAN Cures Act | Introduced | No recorded vote in our record |
| S. 2903Safe Step Act | Introduced | No recorded vote in our record |
| S. 3841Last Sale Valuation Act of 2026 | Introduced | No recorded vote in our record |
| S. 4440Clinical Trial Modernization Act | Introduced | No recorded vote in our record |
Issues named: Copyright/Patent/Trademark (1), Health Issues (1), Labor Issues/Antitrust/Workplace (1), Medicare/Medicaid (1), Pharmacy (1), Tariff (miscellaneous tariff bills) (1), Taxation/Internal Revenue Code (1), Trade (domestic/foreign) (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| ASTRAZENECA PHARMACEUTICALS LPHealth Issues, Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Tariff (miscellaneous tariff bills), Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
| Member | Paid to, as reported | Amount | Date | Report |
|---|---|---|---|---|
| Brian K. Fitzpatrick RRepublican | BRIAN FITZPATRICK FOR ALL OF USFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $1,000 | The report on LDA.gov | |
| Josh Gottheimer DDemocrat | JOSH FOR JERSEYFrom ALEXION PHARMACEUTICALS INC PAC | $1,000 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom ALEXION PHARMACEUTICALS INC PAC | $2,500 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $1,500 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | PEOPLE IN RURAL AREAS TRANSFORM ELECTIONS PIRATE PACFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $3,500 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | PEOPLE IN RURAL AREAS TRANSFORM ELECTIONS PIRATE PACFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $2,500 | The report on LDA.gov | |
| Andrea Salinas DDemocrat | ANDREA SALINAS FOR OREGONFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $2,500 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom ALEXION PHARMACEUTICALS INC PAC | $1,000 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom ALEXION PHARMACEUTICALS INC PAC | $2,500 | The report on LDA.gov | |
| Sarah McBride DDemocrat | MCBRIDE FOR DELAWARE INCFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $2,500 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $2,500 | The report on LDA.gov | |
| Brian K. Fitzpatrick RRepublican | BRIAN FITZPATRICK FOR ALL OF USFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $1,000 | The report on LDA.gov | |
| Sarah McBride DDemocrat | MCBRIDE FOR DELAWARE INCFrom ZENECA INC POLITICAL ACTION COMMITTEE AZPAC | $2,500 | The report on LDA.gov |
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.